Early Career Award in Cancer: To uncover, understand and exploit the estrogen-oncolytic virus crosstalk to improve therapy
Early Career Award in Cancer: To uncover, understand and exploit the estrogen-oncolytic virus crosstalk to improve therapy
批准号:
446155
负责人:
Bourgeois-Daigneault Marie-Claude
金额:
$1.82万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-10-01 至 2021-10-01
中文摘要
我们的研究重点是提高溶瘤病毒治疗乳腺癌的疗效。溶瘤病毒是在不损害正常器官的情况下感染并杀死癌细胞的病毒。它们可以通过静脉注射给癌症患者来杀死他们
英文摘要
Our research is focused on improving the efficacy of oncolytic viruses for breast cancer treatment. Oncolytic viruses are viruses that infect and kill cancers without damaging normal organs. They can be administered to cancer patients intravenously to kil
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating the role of the immunoproteasome in the efficacy of oncolytic virotherapy against breast cancer
-
批准号:453483
-
项目类别:Operating Grants
-
资助金额:$4.37万
-
财政年份:2021
-
负责人:Bourgeois-Daigneault Marie-Claude
-
依托单位:
To uncover, understand and exploit the estrogen-oncolytic virus crosstalk to improve therapy
-
批准号:433704
-
项目类别:Operating Grants
-
资助金额:$56.01万
-
财政年份:2020
-
负责人:Bourgeois-Daigneault Marie-Claude
-
依托单位:
Oncolytic Virus Therapy for the Treatment of Triple Negative Breast Cancer: coupling oncolytic viruses and immunotherapy
-
批准号:318678
-
项目类别:Fellowship Programs
-
资助金额:$8.74万
-
财政年份:2014
-
负责人:Bourgeois-Daigneault Marie-Claude
-
依托单位:
海外基金